Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Paul David C
   2. Issuer Name and Ticker or Trading Symbol
GLOBUS MEDICAL INC [GMED] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Executive Chairman
(Last)
(First)
(Middle)
VALLEY FORGE BUSINESS CENTER, 2560 GENERAL ARMISTEAD AVENUE		 3. Date of Earliest Transaction (Month/Day/Year)
04/26/2018
(Street)

AUDUBON, PA 19403		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 04/26/2018   M   18,461 A $ 4.88 1,096,461 D  
Class A Common Stock 04/26/2018   S(1)   18,461 D $ 51.8068 (2) 1,078,000 D  
Class A Common Stock 04/26/2018   M   18,461 A $ 11.8625 1,096,461 D  
Class A Common Stock 04/26/2018   S(1)   18,461 D $ 51.8068 (2) 1,078,000 D  
Class A Common Stock 04/26/2018   M   18,461 A $ 10.66 1,096,461 D  
Class A Common Stock 04/26/2018   S(1)   18,461 D $ 51.8068 (2) 1,078,000 D  
Class A Common Stock 04/26/2018   M   15,000 A $ 15.34 1,093,000 D  
Class A Common Stock 04/26/2018   S(1)   15,000 D $ 51.8068 (2) 1,078,000 D  
Class A Common Stock 04/26/2018   M   48,000 A $ 13.04 1,126,000 D  
Class A Common Stock 04/26/2018   S(1)   48,000 D $ 51.8068 (2) 1,078,000 D  
Class A Common Stock 04/26/2018   M   60,000 A $ 23.95 1,138,000 D  
Class A Common Stock 04/26/2018   S(1)   60,000 D $ 51.8068 (2) 1,078,000 D  
Class A Common Stock 04/26/2018   M   98,958 A $ 24.1 1,176,958 D  
Class A Common Stock 04/26/2018   S(1)   98,958 D $ 51.8068 (2) 1,078,000 D  
Class A Common Stock 04/26/2018   M   40,625 A $ 25.52 1,118,625 D  
Class A Common Stock 04/26/2018   S(1)   40,625 D $ 51.8068 (2) 1,078,000 D  
Class A Common Stock 04/26/2018   M   43,750 A $ 26.27 1,121,750 D  
Class A Common Stock 04/26/2018   S(1)   43,750 D $ 51.8068 (2) 1,078,000 D  
Class A Common Stock 04/26/2018   S(1)   363,284 D $ 51.8068 (2) 714,716 D  
Class A Common Stock 04/27/2018   S(1)   29,066 D $ 51.7831 (3) 685,650 D  
Class A Common Stock 04/30/2018   S(1)   72,938 D $ 51.8053 (4) 612,712 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy Class A Common Stock) $ 4.88 04/26/2018   M     18,461   (5) 08/06/2019 Class A Common Stock 18,461 $ 0 0 D  
Stock Option (Right to Buy Class A Common Stock) $ 11.8625 04/26/2018   M     18,461   (6) 06/16/2020 Class A Common Stock 18,461 $ 0 0 D  
Stock Option (Right to Buy Class A Common Stock) $ 10.66 04/26/2018   M     18,461   (7) 10/27/2021 Class A Common Stock 18,461 $ 0 0 D  
Stock Option (Right to Buy Class A Common Stock) $ 15.34 04/26/2018   M     15,000   (8) 08/29/2022 Class A Common Stock 15,000 $ 0 0 D  
Stock Option (Right to Buy Class A Common Stock) $ 13.04 04/26/2018   M     48,000   (9) 01/24/2023 Class A Common Stock 48,000 $ 0 0 D  
Stock Option (Right to Buy Class A Common Stock) $ 23.95 04/26/2018   M     60,000   (10) 01/23/2024 Class A Common Stock 60,000 $ 0 0 D  
Stock Option (Right to Buy Class A Common Stock) $ 24.1 04/26/2018   M     98,958   (11) 01/20/2025 Class A Common Stock 98,958 $ 0 26,042 D  
Stock Option (Right to Buy Class A Common Stock) $ 25.52 04/26/2018   M     40,625   (12) 01/25/2026 Class A Common Stock 40,625 $ 0 34,375 D  
Stock Option (Right to Buy Class A Common Stock) $ 26.27 04/26/2018   M     43,750   (13) 01/30/2027 Class A Common Stock 43,750 $ 0 106,250 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Paul David C
VALLEY FORGE BUSINESS CENTER
2560 GENERAL ARMISTEAD AVENUE
AUDUBON, PA 19403		   X   X   Executive Chairman  

Signatures

 /s/ Eric I. Schwartz, Attorney-in-Fact   04/30/2018
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
(2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
(3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.75 to $51.8558, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
(4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.75 to $51.935, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
(5) These options were granted on August 6, 2009, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2010, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
(6) These options were granted on June 16, 2010, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2011, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
(7) These options were granted on October 27, 2011, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2012, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
(8) These options were granted on August 29, 2012, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2013, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
(9) These options were granted on January 24, 2013, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
(10) These options were granted on January 23, 2014, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2015, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
(11) These options were granted on January 20, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
(12) These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
(13) These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.